Latest News

Micot Pharma’s MT200605 Achieves Primary Endpoint in Phase II Trial, Novel Integrated Multi-stage Neuroprotection Mechanism to Be Presented at WSC 2026

HONG KONG, August 7, 2026 - (ACN Newswire) - On August 3, 2026, Shaanxi Micot Pharmaceutical Technology Co., Ltd. ("Micot Pharma"; 2335.HK) announced positive topline data...

Doubleview Advances 2026 Drill Program at Hat; Three Independent Target Methods Converge on Four Priority Locations – Pad 1 Mineralization Intersected, Drilling Advances to...

Doubleview Gold Corp. (TSXV: DBG) (OTCQX: DBLVF) (FSE: 1D4) ("Doubleview" or the "Company") is pleased to provide an update on its 2026 drill program...

Popular:

GMG Announces Updated Battery Brand

Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) ("GMG"...

Business

Events

Marketing

Technology

Medical